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Abstract
Background: Congenital heart disease (CHD) is the most common congenital anomaly in newborns. This study was 
performed to determine the live birth incidence of CHD by ethnicity and sex in Gorgan, Northern Iran.
Methods: In this longitudinal, hospital-based study, 18162 live births in Dezyani Hospital in Gorgan, North of Iran, 
were screened for CHD, from 2007 through 2009. Clinical examination, echocardiography, color Doppler, and cardio 
catheterization were used as diagnostic tools. Sex, ethnicity, and type of CHD for each case were recorded in a pre-designed 
questionnaire. 
 Results: The incidence rates of CHD in the native Fars, Sistani, and Turkmen subjects were 5.73 (95%CI: 4.53-7.15), 
12.27 (95%CI: 8.74-16.73), and 15.93 (95%CI: 10.00-24.02) per 1000 live births, respectively. The Turkmen to native Fars 
and Sistani to native Fars relative risk for congenital CHD malformations was 2.77 (95%CI: 1.73-4.44; p value < 0.001) 
and 1.29 (95%CI: 0.77-2.18; p value < 0.323), respectively. While atrial septal defect was the most common lesion in the 
native Fars subjects (2.14 per 1000 [95%CI: 1.42-3.06]) and in the Sistani subjects (2.84 per 1000 [95%CI: 1.29-5.36]), in 
the Turkmen subjects, ventricular septal defect (4.36 per 1000 [95%CI: 1.59-9.43]), followed by atrial septal defect, was the 
most frequent lesion.
Conclusion: This study showed that the incidence and pattern of CHD among live births in Gorgan, North of Iran, varied 
according to ethnicity. The risk of CHD was higher in the Turkmen and Sistani groups than in the Fars population. 
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Introduction
Congenital heart disease (CHD) is the most common and 
serious congenital anomaly in newborns with a major impact 
on infant morbidity, mortality, and health care costs.1-4 
Determining the prevalence and pattern of CHD can help 
pediatricians and public health professionals better assess 
health care needs, evaluate potential clusters, and recommend 
valuable changes in health policies (Vaidyanathan B, 
Krishna kumar R. The global burden of congenital heart 
disease. Congenital Cardiology Today 2005;3:1-8.). CHD 
has annual rates of 4 to 50 per 1000 live births and is as 
such an extremely prevalent defect.5 Several studies in Iran 
have reported CHD prevalence rates of between 0.92-8.6 per 
1000.6, 7
CHD is a multifactorial disease. Indeed, CHD can be allied 
to defects in chromosomes or genes as well as environmental 
factors.8 Racial/ethnic differences have been previously 
highlighted in relation to the prevalence of CHD.9-14 
Differences in genetic predisposition, environmental 
exposures, access to care (diagnosis of CHD), and response 
to physiologically-based CHD interventions have been 
cited as probable reasons behind the role of racial/ethnic 
differences in the prevalence of CHD.8, 15, 16 Also believed 
to be influential in CHD prevalence are sex differences.17, 
18 Be that as it may, there is currently a paucity of data on 
differences in CHD rates with respect to maternal race/
ethnicity and infant’s sex.8, 19, 20
There are three major ethnic groups, namely native Fars, 
Turkmen, and Sistani, in northern Iran. Given the dearth of 
information on the incidence and pattern of CHD vis-à-vis 
ethnicity, we sought to determine the live birth prevalence 
of CHD by race/ethnicity-sex in the northern Iranian city of 
Gorgan.
Methods
This longitudinal and hospital-based investigation was 
undertaken on 18162   live births to identify all newborns 
with congenital heart malformations born between January 
1, 2007 and December 31, 2009, in Dezyani (a teaching and 
referral hospital   which is the main site for about 80% of 
deliveries in Gorgan, the capital city of the Golestan Province 
in the north of Iran). This hospital has an annual rate of more 
than 6000 deliveries, accounting for 20% of all annual births 
in the Golestan Province and the largest portion of deliveries 
(80%) in the city of Gorgan itself. The Golestan Province 
has a population of about 1.8 million and covers an area of 
about 20460 km2. 
The study was approved by the Ethic Committee of Golestan 
University of Medical Sciences, and parental consent was 
obtained from the parents of all the subjects along with a 
clearance from the institutional Ethics Committee.
The patients were primarily from moderate to low 
socioeconomic class families. All live newborns delivered 
in this hospital during the investigation were examined 
and screened for CHD. Each live newborn was visited by 
a neonatologist. Newborns with cardiac symptoms were 
referred to the Heart Clinic, where they were managed 
by pediatric cardiologists.  Clinical examination, two-
dimensional echocardiography, color Doppler, and cardiac 
catheterization were implemented as the definitive tools for 
the diagnosis of CHD.
Different types of CHD considered for the present 
investigation were comprised of ventricular septal defect 
(VSD), atrial septal defect (ASD), Tetralogy of Fallot, patent 
ductus arteriosus (PDA), pulmonary stenosis, transposition 
of the great arteries, total anomalous pulmonary venous 
connection, partial anomalous pulmonary venous connection, 
pulmonary atresia, single ventricle, Ebstein’s anomaly, and 
complex CHDs (various types of CHDs existing together, 
including rare types of CHDs). The recorded variables 
included the date of birth, sex, type of malformations, 
ethnicity of parents and the presence of other congenital 
malformations. The total number of live figures of every 
year was recorded. According to their ethnicity, three 
ethnic groups (native Fars, Turkmen, and Sistani) residing 
in this region were considered. The native Fars group is 
the predominant inhabitant of the region, the Turkmen are 
those who emigrated from the central Asia more than three 
centuries ago, and the Sistani people emigrated from the 
Iran–Pakistan–Afghanistan border (Sistan and Baluchestan 
Province in the South-East of Iran) more than half a century 
ago. Ethnicity was determined based on maternal self-report.
Statistical Analysis
The descriptive data are presented as percentages. The 
descriptive statistics were calculated for CHD prevalence 
per 1000 live births. The prevalence of CHD was calculated 
as follows: annual rate = CHD cases / total live births. 
Confidence interval (95%CI) for prevalence was calculated 
using binomial exact methods. STATA8/SE statistical 
package was employed for statistical analysis. A p value < 
0.05 was considered significant.
Results
The incidence rates of CHD were 5.73 (95%CI: 4.53-7.15 
[male = 6.41 and female = 5.03]), 12.27 (95%CI: 8.74-16.73 
[male = 13.12 and female = 11.40]), and 15.93 (95%CI: 
10.00-24.02 [male = 15.80 and female = 16.05]) per 1000 
live births in the native Fars, Sistani, and Turkmen groups, 
respectively (Table 1).
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Table 1. Rate of congenital heart disease per 1000 according to ethnicity and 
sex in northern Iran (2007-2009)
Ethnicity Total Male Female
Native Fars 5.73 6.41 5.03
Turkmen 15.93 15.80 16.05
Sistani 12.27 13.12 11.40
The male-to-female relative risk for CHD was 1.17 
(95%CI: 0.84-1.63; p value = 0.343). The Turkmen to native 
Fars and Sistani to native Fars relative risk for CHD was 
2.77 (95%CI: 1.73-4.44; p value < 0.001) and 1.29 (95%CI: 
0.77-2.18 p value = 0.323), respectively (Table 2).
The pattern and number of CHD according to gender and 
ethnicity are depicted in Table 3. 
In the native Fars ethnic group, ASD was the most common 
lesion (2.14 per 1000, 95%CI: 1.42-3.06), followed by ASD 
with VSD (0.73 per 1000, 95%CI: 0.35-1.35) and VSD and 
PDA (0.44 per 1000, 95%CI: 0.16-0.95), respectively. The 
rate of ASD in the males and females was 2.92 and [1.33] per 
1000, respectively (Table 4). 
In the Sistani ethnic group, ASD was the most common 
lesion (2.84 per 1000, 95%CI: 1.29-5.36), followed by VSD 
and PDA (1.89 per 1000, 95%CI: 0.69-4.10). The rate of 
ASD with VSD in the males and females was 1.25 and 0.63 
per 1000, respectively (Table 4). 
In the Turkmen ethnic group, VSD with ASD was the most 
frequent lesion (4.36 per 1000, 95%CI: 1.59-9.43), followed 
by ASD (3.63 per 1000, 95% CI: 1.17-8.42), VSD (2.90 per 
1000, 95%CI: 0.79-7.40), and PDA (2.17 per1000, 95%CI: 
0.44-6.33). The rate of VSD with ASD in the males and 
females was 2.88 and 5.87 per 1000, respectively (Table 4). 
The rates of ASD, ASD with VSD, VSD, and PDA in the 
male and female infants were 2.72 and 2.01 per 1000, 0.76 
and 1.34 per 1000, 1.30 and 0.33 per 1000, and 0.65 and 1.01 
per 1000, respectively (Table 4).
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Table 2. Association between sex and ethnicity with congenital malformations incidence 
Live Newborns 
Newborns with Congenital 
Malformations % Relative risk 95% CI P value
Sex
Female 8957 63 0.70 1 -
Male 9205 76 0.82 1.17 0.84-1.63    0.343
Ethnicity
Fars 13603 78 0.57 1 -
Turkmen 1381 22 1.59 2.77 1.73-4.44 < 0.001
Sistani 3178 39 1.22 1.29 0.77-2.18    0.322
 
Table 3. Cardiovascular malformations distribution by ethnicity and sex
Ethnicity Ethnicity
Native Fars Turkmen Sistani Native Fars Turkmen Sistani 
Male female Male female Male female Male female Male female Male female
ASD 20 9 2 3 3 6 VSD & ASD & PDA 3 1 0 0 0 0
VSD 3 2 4 0 5 1 PS & TR & VSD 0 0 0 0 2 0
PDA 3 3 0 3 3 3 MVP 1 0 0 0 0 0
ASD & VSD 3 7 2 4 2 1 COA & PDA & PH 0 1 0 0 0 0
TOF 0 1 0 0 1 0 TR & ASD 1 3 0 0 0 1
MR 1 0 1 0 0 0 TR & PDA 0 0 0 0 0 1
ASD & PDA 0 1 0 0 1 1 PE 0 0 0 0 0 1
VSD & PDA 0 0 0 0 1 1 VSD & PS 1 0 0 0 0 0
TR 2 1 0 1 0 0 PR 1 1 0 0 0 0
PH 1 0 0 0 0 0 PDA & TGA 0 0 0 0 0 1
PS 1 2 0 0 1 0 EA 1 0 0 0 0 0
PFO 1 0 0 0 0 0 ASD & TGA 1 0 0 0 0 1
TR & PR 0 0 1 0 2 0 PS & ASD 0 1 0 0 0 0
PR & PS 0 0 1 0 0 0 TGA 0 1 0 0 0 0
ASD, Atrial septal defect; VSD, Ventricular septal defect; PDA, Patent ductus arteriosus; TOF, Tetralogy of Fallot; MR, Mitral regurgitation; TR, Tricuspid 
regurgitation; PH, Pulmonary hypertension; PS, Pulmonary stenosis; PFO, Patent foramen ovale; PR, Pulmonary regurgitation; MVP, Mitral valve prolepse; 
COA, Coarctation of the aorta; PE, Pericardial effusion; TGA ,Transposition of great arteries; EA, Ebstein anomaly 
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Discussion
This study was conducted to explore the incidence rate and 
pattern of CHD for native Fars, Turkmen, and Sistani infants 
living in Gorgan, northern Iran. According to our results, the 
Turkmen newborns (15.93 per 1000) had the highest overall 
incidence rate of CHD, followed by the Sistani (12.27 per 
1000) and native Fars (5.73per 1000) infants.
Several studies have reported racial/ethnic differences in 
the prevalence of CHD.9, 10, 12, 13, 21 The Sadig et al. study9 
(1995) showed that the estimated prevalence of congenital 
heart defects requiring hospital admission was higher in 
Asian infants than in non-Asian ones (9.45 per 1000 vs. 
4 56 per 1000; p value < 0.0001). Canfield et al.10 (2006) 
reported that, compared to the infants of non-Hispanic white 
mothers, the infants of non-Hispanic black mothers had a 
significantly high birth prevalence of Tetralogy of Fallot.  In 
a population-based study, Correa-Villasenor et al.21 (1991) 
demonstrated that the white/black variation in cardiovascular 
malformations was found for several diagnostic groups of 
CHD. Indeed, Nembhard et al.13 (2009) reported that the 
Hispanic infants had the highest overall CHD prevalence 
(80.09 per 10 000 live births), followed by the non-Hispanic-
white (79.11 per 10000 live births) and non-Hispanic black 
infants (77.67 per 10000 live births). Furthermore, Botto et 
al.12 (2001) showed that the incidence rate of CHD in the 
USA from 1968 through 1997 was 59.35 and 66.51 per 
10000 in their white and black infants, respectively (RR = 
1.12, 95%CI: 1.06-1.18).  
Differences in genetic predisposition, environmental 
exposures, access to care (diagnosis of CHDs), and 
response to physiologically-based CHD interventions may 
be the causes of racial/ethnic differences in the prevalence 
of CHD.8, 15, 16 Interpretation in terms of genetic and 
environmental causation, however, is not straightforward. 
For example, racial and ethnic variations are often associated 
with socioeconomic differences, lifestyle variation, cultural 
factors, and other factors that indicate environmental 
exposures according to the Botto et al. study12 in 2001.
In the present study, ASD, followed by ASD with VSD, 
was the most common lesion in the native Fars and Sistani 
ethnic groups, whereas in the Turkmen ethnic group, VSD 
with ASD, followed by ASD, was the most frequent lesion.
According to the Boto study12 (2001), a high overall 
occurrence rate for the blacks by comparison with the whites 
was primarily driven by a higher occurrence of peripheral 
pulmonic stenosis and ASD. However, transposition of the 
great arteries, truncus arteriosus, coarctation of the aorta, and 
aortic stenosis occurred more often among the whites. Also, 
racial differences were seen also within some broad defect 
categories. For example, transposition of the great arteries, 
but not tetralogy of Fallot, was more common among the 
whites. Similarly, among the left-side obstructive defects, 
coarctation of the aorta, but not hypoplastic left heart, was 
more common among the whites.
Nembhard13 (2010) drew upon data from the Florida Birth 
Defects Registry (FBDR) during 1998-2003 and reported 
that compared to the non-Hispanic whites, the non-Hispanic 
blacks had high rates of pulmonary valve atresia/stenosis but 
lower frequencies of aortic valve atresia/stenosis and VSD. 
The Hispanics had lower rates of aortic valve atresia/stenosis 
and atrioventricular septal defects than the non-Hispanic 
whites. Elsewhere, the Sadig et al. study9 (1995) showed 
that the Asian infants had a higher proportion of complex 
CHD (7% vs. 2.1%; p value < 0.001), whereas coarctation 
of the aorta was more common in the non-Asians (3% vs. 
9.1%; p value = 0.003). Also, the proportion of admissions 
for persistent arterial duct seemed to be significantly 
higher in the Asian infants than in the non-Asian infants. 
Furthermore, a study carried out in Chinese people reported 
that in the live births, the top three lesions were VSD, PDA, 
and ASD, which accounted for 34.0%, 23.7%, and 10.8% of 
all lesions, respectively.22 Also, the WU et al. study23 (2010) 
in Taiwan demonstrated that  VSD was the most common 
defect, followed by secundum ASD. In addition, female 
predominance was observed in VSD, ASD II, PDA, and 
endocardial cushion defect, while male predominance was 
seen in transposition of the great arteries, tetralogy of Fallot, 
PDA, and pulmonary stenosis.
The Fixler study14 reported that the white children had 
higher prevalence rates for aortic stenosis, endocardial 
cushion defect, and VSD. In that study, the Mexican-
American children had the lowest rate for hypoplastic left 
heart syndrome.
In our study, the incidence rates of ASD and VSD in the 
native Fars group and VSD in Turkmen and Sistani groups 
were more common in the males than in the females, whereas 
ASD with VSD in the native Fars and Turkmen groups, 
and ASD in the Sistani subjects were more common in the 
females than in the males.
Table 4. Rate of selected congenital heart disease per 1000 according to ethnicity and gender
Ethnicity
ASD ASD & VSD VSD PDA
Male Female Male Female Male Female Male Female
Native Fars 2.95 1.32 0.44 1.03 0.44 0.29 0.44 0.44
Turkmen 2.90 4.36 2.90 5.83 5.83 0 0 4.36
Sistani 1.89 3.79 1.26 0.63 3.15 0.63 1.89 1.89
ASD, Atrial septal defect; VSD, Ventricular septal defect; PDA, Patent ductus arteriosus 
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The Nembhard study8 (2010) by using data from the 
Florida Birth Defects Registry (FBDR) during 1998–2003 
reported that compared with the non-Hispanic whites, the 
non-Hispanic black males had significantly increased rates 
of pulmonary valve atresia/ stenosis but lower prevalence 
of aortic valve atresia/stenosis and VSD. Also, the Hispanic 
males had lower rates of aortic valve atresia/stenosis, 
coarctation of the aorta, and VSD. On the other hand, the 
non-Hispanic black females had significantly lower rates of 
VSD and the Hispanic females had lower rates of Tetralogy 
of Fallot, VSD, and atrioventricular septal defect than the 
non-Hispanic whites.
According to the Mc Bride et al. study20 (2005), the 
prevalence ratios were significantly higher for the male sex. 
Also, the racial difference of higher rates for the whites 
compared to the blacks was confirmed for coarctation of 
the aorta and obstruction of the left ventricular outflow tract 
malformations. However, the rate differences between the 
white and black groups were not significant for the aortic 
valve stenosis and hypoplastic left heart syndrome cases.
Female predominance was reported in VSD, ASD, PDA, 
and endocardial cushion defect, whereas male predominance 
was observed in the transposition of the great arteries, 
Tetralogy of Fallot, PDA, and pulmonary stenosis.23
Storch and  Mannick19 (1992) reported that the prevalence 
of atrioventricular canal defect per 1000 live births was 
significantly higher for the black females than that for the 
black males and for the white females compared to the white 
males. Also, complete transposition of the great arteries was 
significantly higher for the white males than for the white 
females. In contrast, transposition of the great arteries was not 
significantly different between the black males and the black 
females. Additionally, they demonstrated that obstructive 
left heart syndrome aortic stenosis and/or coarctation of the 
aorta was significantly higher for the white males than that 
for the white females.
The explanations for differences in the sex ratios by 
ethnicity are not readily clear. The Shaw et al. study24 
reported that many defects have deviations in the ratio of 
the affected males versus the affected females and Gorlin25 
found differences in the sex ratios by ethnicity for infants 
with cleft lips; nonetheless, no explanations for these 
deviations have been forthcoming. It is possible that the 
racial/ethnic differences can be the result of the differential 
loss of CHD-affected pregnancies during the gestational 
period rather than true differences in the incidence of CHD. 
As our study was conducted only on live births, we did not 
report spontaneous miscarriages, fetal deaths, and elective 
terminations. Needless to say, incidence can be affected by 
the aforementioned items.26
It is also possible that differences in the sex ratios by 
ethnicity might be due to racial/ethnic and sex-specific 
differences in the diagnosis of CHD after birth8 or might 
be in consequence of having access to pediatric care and 
treatment.
First and foremost among the limitations of the current 
study is that the true incidence of CHD within a population 
can only be determined with complete ascertainment 
of all fetal outcomes and we were not able to completely 
establish all fetal outcomes, primarily because spontaneous 
and induced abortions before 20 weeks’ gestation were not 
documented in this study. And nor were we able to state the 
number of severely ill children who died during the initial 
steps of resuscitation (before echocardiography could be 
performed). Indeed, we only had access to the gender and 
ethnicity in the healthy newborns (without malformations); 
therefore, we could not adjust the effect of such potential 
confounders as the mother’ age and parity in this study.
 
Conclusion
For the first time, we found racial/ethnic and sex-specific 
differences in the incidence and pattern of CHD in Gorgan, 
northern Iran. Our findings showed a significant difference in 
CHD between the native Fars, Turkmen, and Sistani infants. 
While ASD was more common among the native Fars and 
Sistani infants, ASD with VSD was more frequent in the 
Turkmen children.
These findings should help establish a database for future 
studies focusing on the etiology and ethnic disparity of CHD 
in the region. The findings could lead to valuable changes 
in health policies for the improvement of diagnostic and 
therapeutic facilities.
CHD needs regular monitoring so as to permit optimal 
growth and development. Early diagnosis and timely 
intervention will, therefore, reduce the morbidity and 
mortality to a large extent.
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